Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea; Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, Republic of Korea.
Respir Med. 2013 Oct;107(10):1509-14. doi: 10.1016/j.rmed.2013.07.016. Epub 2013 Aug 6.
There has been no large-scale and comprehensive study of the differences between asthma in elderly asthmatics (EA) and non-elderly (i.e. young) asthmatics (NEA).
We performed principal component analysis (PCA) using 2067 asthmatics (434 EA and 1633 NEA) from the Korean Cohort for Reality and Evolution of adult Asthma (COREA). EA was defined as asthmatics with the chronological age of 65 or more and eleven clinical variables measured at enrollment were used for PCA; symptom score, symptom duration, number of exacerbation during previous one year, smoking pack year, number of controller medications, body mass index, predicted % of FEV1, predicted % FVC, post-bronchodilator FEV1/FVC ratio, atopy index and number of eosinophils in peripheral blood.
PCA of all asthmatics showed that EA and NEA were distinctly separated by the first and second principal component on the plot of individual asthmatics according to their scores. For further analysis, we divided all asthmatics into the EA and the NEA group and performed PCA again in each group. The first four principal components with eigenvalues ≥ 1.0 were identified in both groups and they explained 55.5% of the variance in the EA group and 52.4% in the NEA group respectively. Clinical variables showed distinctly different patterns of loading on the first four principal components between the EA and the NEA group.
EA and NEA have different compositional patterns underlying their clinical variables. These observations helped in understanding the differences between EA and NEA from the integrated view covering various clinical aspects.
目前尚无针对老年哮喘患者(EA)与非老年(即年轻)哮喘患者(NEA)之间差异的大规模、全面研究。
我们对来自韩国成人哮喘现实与演变队列研究(COREA)的 2067 例哮喘患者(434 例 EA 和 1633 例 NEA)进行主成分分析(PCA)。EA 定义为年龄≥65 岁的哮喘患者,纳入研究时测量的 11 项临床变量用于 PCA;症状评分、症状持续时间、前一年的哮喘加重次数、吸烟包年数、控制性药物的使用数量、体重指数、预计第 1 秒用力呼气量占预计值的百分比(FEV1%pred)、预计用力肺活量占预计值的百分比(FVC%pred)、支气管扩张剂后 FEV1/FVC 比值、变应原指数和外周血嗜酸性粒细胞计数。
所有哮喘患者的 PCA 显示,根据个体哮喘患者的得分,EA 和 NEA 在个体患者的图上通过第一和第二主成分明显分开。为了进一步分析,我们将所有哮喘患者分为 EA 和 NEA 组,并在每组中再次进行 PCA。在两组中均确定了前四个特征值≥1.0 的主成分,它们分别解释了 EA 组和 NEA 组中 55.5%和 52.4%的方差。临床变量在 EA 组和 NEA 组中,在四个主成分上的负荷呈现明显不同的模式。
EA 和 NEA 的临床变量具有不同的组成模式。这些观察结果有助于从涵盖各个临床方面的综合视角理解 EA 和 NEA 之间的差异。